Zeerleder, S.; Engel, R.; Zhang, T.; Roem, D.; van Mierlo, G.; Wagenaar-Bos, I.; van Ham, S.M.; Wuhrer, M.; Wouters, D.; Jongerius, I.
Sugar Matters: Improving In Vivo Clearance Rate of Highly Glycosylated Recombinant Plasma Proteins for Therapeutic Use. Pharmaceuticals 2021, 14, 54.
https://doi.org/10.3390/ph14010054
AMA Style
Zeerleder S, Engel R, Zhang T, Roem D, van Mierlo G, Wagenaar-Bos I, van Ham SM, Wuhrer M, Wouters D, Jongerius I.
Sugar Matters: Improving In Vivo Clearance Rate of Highly Glycosylated Recombinant Plasma Proteins for Therapeutic Use. Pharmaceuticals. 2021; 14(1):54.
https://doi.org/10.3390/ph14010054
Chicago/Turabian Style
Zeerleder, Sacha, Ruchira Engel, Tao Zhang, Dorina Roem, Gerard van Mierlo, Ineke Wagenaar-Bos, Sija Marieke van Ham, Manfred Wuhrer, Diana Wouters, and Ilse Jongerius.
2021. "Sugar Matters: Improving In Vivo Clearance Rate of Highly Glycosylated Recombinant Plasma Proteins for Therapeutic Use" Pharmaceuticals 14, no. 1: 54.
https://doi.org/10.3390/ph14010054
APA Style
Zeerleder, S., Engel, R., Zhang, T., Roem, D., van Mierlo, G., Wagenaar-Bos, I., van Ham, S. M., Wuhrer, M., Wouters, D., & Jongerius, I.
(2021). Sugar Matters: Improving In Vivo Clearance Rate of Highly Glycosylated Recombinant Plasma Proteins for Therapeutic Use. Pharmaceuticals, 14(1), 54.
https://doi.org/10.3390/ph14010054